INAB
Price
$0.17
Change
-$0.00 (-0.00%)
Updated
Apr 2 closing price
Capitalization
13.86M
35 days until earnings call
SRZN
Price
$11.86
Change
+$0.74 (+6.65%)
Updated
Apr 2 closing price
Capitalization
38.54M
Ad is loading...

INAB vs SRZN

Header iconINAB vs SRZN Comparison
Open Charts INAB vs SRZNBanner chart's image
IN8bio
Price$0.17
Change-$0.00 (-0.00%)
Volume$705.3K
Capitalization13.86M
Surrozen
Price$11.86
Change+$0.74 (+6.65%)
Volume$8.59K
Capitalization38.54M
INAB vs SRZN Comparison Chart
Loading...
INAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INAB vs. SRZN commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INAB is a Hold and SRZN is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (INAB: $0.17 vs. SRZN: $11.86)
Brand notoriety: INAB and SRZN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: INAB: 10% vs. SRZN: 46%
Market capitalization -- INAB: $13.86M vs. SRZN: $38.54M
INAB [@Biotechnology] is valued at $13.86M. SRZN’s [@Biotechnology] market capitalization is $38.54M. The market cap for tickers in the [@Biotechnology] industry ranges from $308.32B to $0. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INAB’s FA Score shows that 1 FA rating(s) are green whileSRZN’s FA Score has 0 green FA rating(s).

  • INAB’s FA Score: 1 green, 4 red.
  • SRZN’s FA Score: 0 green, 5 red.
According to our system of comparison, INAB is a better buy in the long-term than SRZN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INAB’s TA Score shows that 4 TA indicator(s) are bullish while SRZN’s TA Score has 6 bullish TA indicator(s).

  • INAB’s TA Score: 4 bullish, 3 bearish.
  • SRZN’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, SRZN is a better buy in the short-term than INAB.

Price Growth

INAB (@Biotechnology) experienced а -18.37% price change this week, while SRZN (@Biotechnology) price change was +11.26% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -7.56%. For the same industry, the average monthly price growth was -9.64%, and the average quarterly price growth was -14.03%.

Reported Earning Dates

INAB is expected to report earnings on May 08, 2025.

SRZN is expected to report earnings on Mar 21, 2024.

Industries' Descriptions

@Biotechnology (-7.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SRZN($38.5M) has a higher market cap than INAB($13.9M). SRZN YTD gains are higher at: -17.352 vs. INAB (-33.670). SRZN has higher annual earnings (EBITDA): -25.06M vs. INAB (-26.94M). SRZN has more cash in the bank: 31M vs. INAB (11.1M). SRZN has less debt than INAB: SRZN (1.53M) vs INAB (5.03M). SRZN has higher revenues than INAB: SRZN (10M) vs INAB (0).
INABSRZNINAB / SRZN
Capitalization13.9M38.5M36%
EBITDA-26.94M-25.06M108%
Gain YTD-33.670-17.352194%
P/E RatioN/AN/A-
Revenue010M-
Total Cash11.1M31M36%
Total Debt5.03M1.53M329%
TECHNICAL ANALYSIS
Technical Analysis
INABSRZN
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
78%
Momentum
ODDS (%)
N/A
Bullish Trend 1 day ago
77%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 16 days ago
80%
Bullish Trend 14 days ago
84%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 9 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
81%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
View a ticker or compare two or three
Ad is loading...
INAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SRZN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FLL4.240.08
+1.92%
Full House Resorts
CRIS1.480.02
+1.37%
Curis
JOE47.140.59
+1.27%
St Joe Company
EVRI13.720.01
+0.07%
Everi Holdings
K82.45-0.05
-0.06%
Kellanova

INAB and

Correlation & Price change

A.I.dvisor indicates that over the last year, INAB has been loosely correlated with IDYA. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if INAB jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INAB
1D Price
Change %
INAB100%
-1.22%
IDYA - INAB
47%
Loosely correlated
+10.70%
GRI - INAB
37%
Loosely correlated
-17.33%
SNSE - INAB
33%
Loosely correlated
+6.09%
CUE - INAB
30%
Poorly correlated
+5.35%
SRZN - INAB
28%
Poorly correlated
+6.65%
More

SRZN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRZN has been loosely correlated with ATBPF. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if SRZN jumps, then ATBPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRZN
1D Price
Change %
SRZN100%
+6.65%
ATBPF - SRZN
46%
Loosely correlated
N/A
IRON - SRZN
34%
Loosely correlated
+2.93%
ABCZF - SRZN
28%
Poorly correlated
N/A
KMSTF - SRZN
27%
Poorly correlated
N/A
ATHE - SRZN
27%
Poorly correlated
-2.52%
More